-transparent.png){kind=logo}
Using the sequence homology approach for cloning related genes within the G-protein-coupled receptor gene family, we have cloned the gene for the rat beta 1-adrenergic receptor (beta 1-AR). The rat beta 1-adrenergic receptor gene was isolated from a lambda EMBL3 rat genomic DNA library using the hamster beta 2-adrenergic receptor (beta 2-AR) coding sequence as a probe under low stringency hybridization conditions. The rat beta 1-AR gene encodes a protein of 466 amino acids that contains one consensus site for N-linked glycosylation (Asn-15) and three consensus sites for cAMP-dependent protein kinase phosphorylation (Ser-296, Ser-301, and Ser-401). The encoded rat beta 1-AR is 98 and 91% similar at the amino acid level with the human beta 1-AR in the transmembrane domains and in the overall sequence, respectively. Genomic Southern blot and gene dosage analyses indicate that the rat beta 1-AR gene is a single copy gene. The tissue distribution of the rat beta 1-AR mRNA was highest in the pineal gland with other brain regions and peripheral tissues, including the heart, expressing the mRNA at moderate levels. The bacteriophage clone containing the rat beta 1-AR gene with its natural promoter was co-transfected with the selectable marker (pRSVneo) conferring neomycin resistance into beta 1-AR-deficient mouse L cells. Analyses of the selected transfectant demonstrates efficient expression of the beta 1-AR gene and functional receptor. 125I-Labeled iodocyanopindolol bound transfectant membranes with an affinity of KD = 24 pm; the beta 1-AR-selective antagonist ICI 89,406 displaced iodocyanopindolol binding with a Ki approximately 140 times lower than that for the beta 2-AR-selective antagonist ICI 118,551. In addition, in the transfectant cell line, adenylylcyclase was stimulated by beta-adrenergic receptor agonists with the rank order of potency of isoproterenol greater than norepinephrine = epinephrine, consistent with properties expected of the beta 1-AR subtype.
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
December 1991,
Molecular pharmacology,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
October 1997,
Journal of animal science,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
May 1989,
Clinical chemistry,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
August 1990,
Nucleic acids research,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
January 1994,
DNA sequence : the journal of DNA sequencing and mapping,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
July 1997,
Journal of receptor and signal transduction research,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
October 1988,
Proceedings of the National Academy of Sciences of the United States of America,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
January 1993,
Biochemical and biophysical research communications,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
October 1994,
The Journal of biological chemistry,
C A Machida, and
J R Bunzow, and
R P Searles, and
H Van Tol, and
B Tester, and
K A Neve, and
P Teal, and
V Nipper, and
O Civelli
February 2002,
Molecular pharmacology,
